Abstract
5051Background: Men with intermediate-risk prostate cancer represent a clinically heterogeneous group with varying prognoses. High tumor copy number alteration as measured by percent genome aberrat...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
